Consolidated Edison Company of New York, Inc.-エネルギー分野:企業M&A・提携分析

◆英語タイトル:Consolidated Edison Company of New York, Inc. - Power - Deals and Alliances Profile
◆商品コード:DATA8013060
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:発電・エネルギー
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Consolidated Edison Company of New York, Inc. (CECONY), a subsidiary of Consolidated Edison, Inc. is an energy utility that generates, transmits and distributes electricity; supplies natural gas; and generates and supplies steam. The company provides electricity and related services in New York City and most of Westchester County. It supplies natural gas in Manhattan, parts of Queens, the Bronx and most of Westchester County; and produces and delivers steam in Manhattan. The company serves residential, industrial and commercial customers. CECONY is headquartered in New York, the US.

Consolidated Edison Company of New York, Inc. – Power – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Power eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Consolidated Edison Company of New York, Inc., Power, Deals By Year, 2011 to YTD 2017 5
Consolidated Edison Company of New York, Inc., Power Deals By Type, 2011 to YTD 2017 6
Consolidated Edison Company of New York, Inc., Power, Deals By Region, 2011 to YTD 2017 7
Consolidated Edison Company of New York, Inc., Power, Deals By Sector, 2011 to YTD 2017 8
Consolidated Edison Company of New York, Inc., Power, Deals Summary, 2011 to YTD 2017 9
Consolidated Edison Company of New York, Inc., Power, Deal Details 10
Partnerships 10
Consolidated Edison Forms Partnership with SunPower 10
Debt Offering 11
Consolidated Edison Company of New York Prices Public Offering of 4% Series 2017 C Debentures Due 2057 for USD350 Million 11
Consolidated Edison Company of New York Prices Public Offering of 3.125% Series 2017 B Debentures Due 2027 for USD350 Million 12
Consolidated Edison Company of New York Raises USD500 Million in Public Offering of 3.875% Debenture Due 2047 14
Consolidated Edison Company of New York Raises USD500 Million in Public Offering of 4.3% Series 2016-C Debentures Due 2056 15
Consolidated Edison Company of New York Raises USD250 Million in Public Offering of 2.9% Series 2016-B Debentures Due 2026 17
Consolidated Edison Company of New York Raises USD550 Million in Public Offering of 3.85% Series 2016-A Debentures Due 2046 19
Consolidated Edison Company of New York Raises USD850 Million in Public Offering of 4.45% Debentures Due 2044 21
Consolidated Edison Company of New York Raises USD700 Million in Public Offering of 3.95% Debentures Due 2043 22
Consolidated Edison Company of New York Raises USD400 Million in Public Offering of 4.2% Debentures Due 2042 23
Consolidated Edison Company of New York, Inc. – Key Competitors 24
Consolidated Edison Company of New York, Inc. – Key Employees 25
Consolidated Edison Company of New York, Inc. – Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Apr 25, 2017: Con Edison Podcast: Battery Storage Technology In New York City Neighborhoods 27
Mar 14, 2017: Utilities Overwhelmingly Select FirstFuel for Business Customer Engagement in 2016 28
Feb 28, 2017: Con Edison Storing the Future for Energy Customers 29
Jan 11, 2017: Willdan Awarded $75 Million Base Contract for Con Edison Energy Efficiency Program 30
Nov 07, 2016: Green Charge Awarded Contract With Con Edison to Deliver 13 Megawatt Hours of Distributed Energy Storage 31
Oct 31, 2016: Solar Power From Con Edison Rooftops To Benefit Low-Income Customers 32
Sep 20, 2016: Gov. Karyn Polito dedicates new Solar Installation in Westfield, Massachusetts 33
Sep 07, 2016: Tarsier Wins Con Edison Contract for Energy Curtailment 34
Jul 12, 2016: Con Edison Developing Energy Storage System On Wheels 35
May 26, 2016: Con Edison Forecasts Summer Savings; $1.6 Billion Invested For Reliability 36
Apr 25, 2016: NYCHA Reduces Energy Demand, Increases Efficiency Through Collaboration With Con Edison 37
Apr 18, 2016: Con Edison Customers Shining And Saving With More Than 100 Megawatts Of Solar 38
Mar 08, 2016: Dip in Energy Prices Plus Energy Efficiency = Savings 39
Jan 29, 2016: Con Edison Files Electric & Gas Rate Proposals For 2017 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Consolidated Edison Company of New York, Inc., Power, Key Facts, 2016 2
Consolidated Edison Company of New York, Inc., Power, Deals Summary, 2011 to YTD 2017 2
Consolidated Edison Company of New York, Inc., Power, Deals By Year, 2011 to YTD 2017 5
Consolidated Edison Company of New York, Inc., Power Deals By Type, 2011 to YTD 2017 6
Consolidated Edison Company of New York, Inc., Power, Deals By Region, 2011 to YTD 2017 7
Consolidated Edison Company of New York, Inc., Deals By Sector, 2011 to YTD 2017 8
Consolidated Edison Company of New York, Inc., Power, Deals Summary, 2011 to YTD 2017 9
Consolidated Edison Forms Partnership with SunPower 10
Consolidated Edison Company of New York Prices Public Offering of 4% Series 2017 C Debentures Due 2057 for USD350 Million 11
Consolidated Edison Company of New York Prices Public Offering of 3.125% Series 2017 B Debentures Due 2027 for USD350 Million 12
Consolidated Edison Company of New York Raises USD500 Million in Public Offering of 3.875% Debenture Due 2047 14
Consolidated Edison Company of New York Raises USD500 Million in Public Offering of 4.3% Series 2016-C Debentures Due 2056 15
Consolidated Edison Company of New York Raises USD250 Million in Public Offering of 2.9% Series 2016-B Debentures Due 2026 17
Consolidated Edison Company of New York Raises USD550 Million in Public Offering of 3.85% Series 2016-A Debentures Due 2046 19
Consolidated Edison Company of New York Raises USD850 Million in Public Offering of 4.45% Debentures Due 2044 21
Consolidated Edison Company of New York Raises USD700 Million in Public Offering of 3.95% Debentures Due 2043 22
Consolidated Edison Company of New York Raises USD400 Million in Public Offering of 4.2% Debentures Due 2042 23
Consolidated Edison Company of New York, Inc., Key Competitors 24
Consolidated Edison Company of New York, Inc., Key Employees 25

★海外企業調査レポート[Consolidated Edison Company of New York, Inc.-エネルギー分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Damodar Valley Corp:企業の戦略的SWOT分析
    Damodar Valley Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Mmi Holdings Ltd.
    Mmi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report Summary Mmi Holdings Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • BrainScope Company Inc-医療機器分野:企業M&A・提携分析
    Summary BrainScope Company Inc (BrainScope) is a medical device company that offers medical neurotechnology products. The company develops and distributes non-invasive instruments for the treatment of traumatic brain injuries, moderate traumatic brain injury and mild traumatic brain injury. It provi …
  • Armune BioScience Inc-医療機器分野:企業M&A・提携分析
    Summary Armune BioScience Inc (Armune) is a medical device company that develops and commercializes molecular diagnostic and prognostic tests. The company uses genomics and proteomics in cancer to identifying specific sets of genes or proteins. It develops protein signature based diagnostic tests fo …
  • Torm Plc (TRMD A):企業の財務・戦略的SWOT分析
    Torm Plc (TRMD A) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Neurocrine Biosciences Inc (NBIX)-製薬・医療分野:企業M&A・提携分析
    Summary Neurocrine Biosciences Inc (Neurocrine) discovers, develops and commercializes pharmaceutical products for the treatment of neurologic, psychiatric and endocrine related diseases and disorders. Its lead product, Ingrezza (valbenazine) capsule is a US FDA approved selective vesicular monoamin …
  • Invectys SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Invectys SA (Invectys) is a biopharmaceutical company that develops immunotherapy to treat cancer. The company provides product pipeline such as INVAC-1, a DNA vaccine targeting Telomerase; Universal Cancer Peptide vaccine UCPVax. It offers products such as a human telomerase peptide-based v …
  • Westgold Resources Ltd (WGX):企業の財務・戦略的SWOT分析
    Westgold Resources Ltd (WGX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • AFFiRiS AG-製薬・医療分野:企業M&A・提携分析
    Summary Affiris AG (AFFiRiS) is a drug development company that develops and manufactures novel synthetic vaccines against chronic diseases. The company develops customized peptide vaccines based on its proprietary affitome technology for the prevention of Alzheimer's disease, Parkinson's disease, a …
  • Vodafone Group Plc (VOD):企業の財務・戦略的SWOT分析
    Vodafone Group Plc (VOD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cytokinetics Inc (CYTK):企業の財務・戦略的SWOT分析
    Cytokinetics Inc (CYTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Labeyrie Fine Foods:企業の戦略・SWOT・財務情報
    Labeyrie Fine Foods - Strategy, SWOT and Corporate Finance Report Summary Labeyrie Fine Foods - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Royal DSM NV (DSM):製薬・医療:M&Aディール及び事業提携情報
    Summary Royal DSM NV (DSM) is a science-based company with focus on materials, health and nutrition. It produces vitamins, carotenoids, nutritional lipids and other ingredients; specialty plastics; and fiber and resins solutions. DSM develops materials for medical devices and clean energy from crop …
  • Terna SpA (TRN):電力:M&Aディール及び事業提携情報
    Summary Terna SpA (Terna) is an electricity transmission system operator (TSO). It operates high-voltage grid and carries out transmission and dispatching of electricity, maintains transmission infrastructure, plans and constructs the grid, and undertakes grid development projects. It offers special …
  • EQT Corp (EQT):石油・ガス:M&Aディール及び事業提携情報
    Summary EQT Corp (EQT) is an integrated oil and gas company. It operates production fields in Marcellus, Upper Devonian, Ohio Utica and other plays in Appalachian Basin. The company produces and markets natural gas, natural gas liquids (NGL), ethane and crude oil. EQT provides gathering, transmissio …
  • iHeartMedia, Inc.:戦略・SWOT・企業財務分析
    iHeartMedia, Inc. - Strategy, SWOT and Corporate Finance Report Summary iHeartMedia, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Galen Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Galen Ltd (Galen), a subsidiary of Almac Group Ltd is a marketer of pharmaceutical products. The company’s products include trustsaver, calceos, salivix, daunoxome, flotros, histofreezer, laxido, and saline steripoules, among others. It offers products in various therapy areas including angi …
  • Sanlam Limited:企業の戦略・SWOT・財務分析
    Sanlam Limited - Strategy, SWOT and Corporate Finance Report Summary Sanlam Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Nuvaira Inc:医療機器:M&Aディール及び事業提携情報
    Summary Nuvaira Inc (Nuvaira), formerly Holaira Inc is an independent medical device company that strives to develop minimally invasive products for the treatment of obstructive lung diseases. It provides Lung Denervation System, a catheter-based system intended for asthma and chronic obstructive pu …
  • Kracie Holdings Ltd:企業の戦略的SWOT分析
    Kracie Holdings Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆